Klinik Araştırma

Determination of the effects of inflammatory markers on mortality in intensive care patients

Cilt: 5 Sayı: 3 31 Aralık 2022
PDF İndir
EN TR

Determination of the effects of inflammatory markers on mortality in intensive care patients

Öz

Abstract Aim: Mean platelet volume (MPV), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), red cell distribution width (RDW) plays important role as effective factors in predicting mortality and morbidity in various diseases. In the present study we aimed to assess and compare MPV, NLR, PLR and RDW of survived and non-survived patients by examining the blood samples taken within the first hour after admission to our intensive care unit. Methods: This retrospective study included 672 patients who were hospitalized in a mixed 16 bed intensive care unit (ICU) between January 2019 and January 2020. By examining our hospital's computer-based data system, patient data of the survived and non-survived patients who were treated in the ICU were analyzed. Results: The demographic parameters of the patients (gender), concomitant disease, and laboratory parameters including HTC, PLT, WBC, MPV and PLR were not significantly different between the survived and non-survived patients. RDW, albumin, CRP and NLR were found statistically different between the study groups. Conclusions: The elevated RDW, NLR and CRP levels were found more significant than the other inflammatory markers for determining mortality of the critically ill patients. In addition, evaluation of albumin level was found important in defining the prognosis of the intensive care unit patients.

Anahtar Kelimeler

Kaynakça

  1. 1) Pilling LC, Atkins JL, Kuchel GA et al. PLoS One.2008;13(9):e0203504.
  2. 2) Salvagno GL, Sanchis-Gomar F, Picanza A et al. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci.2015;52:86-105.
  3. 3) Pyo JS, Sohn JH, Kang G. Diagnostic and prognostic roles of the mean platelet volume in malignant tumors: a systematic review and meta-analysis. Platelets.2016;27:722-728.
  4. 4) Chu SG, Becker RC,Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb. Haemost. 2010;8:148-156.
  5. 5) Shen J, Ran ZH, Zhang Y, et al. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified cohort analysis. Thromb Res. 2009;123:604-611.
  6. 6) Yazici S, Yazici M, Erer B, et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets.2010;21:122-125.
  7. 7) Sarraf KM, Belcher E, Raevsky E, et al. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137:425-8.
  8. 8) Cho H, Hur H, Kim S, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother. 2009;58:15-23.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri, Anesteziyoloji, Yoğun Bakım

Bölüm

Klinik Araştırma

Yayımlanma Tarihi

31 Aralık 2022

Gönderilme Tarihi

2 Kasım 2022

Kabul Tarihi

26 Aralık 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 5 Sayı: 3

Kaynak Göster

APA
Honca, T., Parlak, A., Öz, H., Sarer, E., & Honca, M. (2022). Determination of the effects of inflammatory markers on mortality in intensive care patients. Journal of Cukurova Anesthesia and Surgical Sciences, 5(3), 389-396. https://doi.org/10.36516/jocass.1187288
AMA
1.Honca T, Parlak A, Öz H, Sarer E, Honca M. Determination of the effects of inflammatory markers on mortality in intensive care patients. J Cukurova Anesth Surg. 2022;5(3):389-396. doi:10.36516/jocass.1187288
Chicago
Honca, Tevfik, Ayşegül Parlak, Hakan Öz, Ebru Sarer, ve Mehtap Honca. 2022. “Determination of the effects of inflammatory markers on mortality in intensive care patients”. Journal of Cukurova Anesthesia and Surgical Sciences 5 (3): 389-96. https://doi.org/10.36516/jocass.1187288.
EndNote
Honca T, Parlak A, Öz H, Sarer E, Honca M (01 Aralık 2022) Determination of the effects of inflammatory markers on mortality in intensive care patients. Journal of Cukurova Anesthesia and Surgical Sciences 5 3 389–396.
IEEE
[1]T. Honca, A. Parlak, H. Öz, E. Sarer, ve M. Honca, “Determination of the effects of inflammatory markers on mortality in intensive care patients”, J Cukurova Anesth Surg, c. 5, sy 3, ss. 389–396, Ara. 2022, doi: 10.36516/jocass.1187288.
ISNAD
Honca, Tevfik - Parlak, Ayşegül - Öz, Hakan - Sarer, Ebru - Honca, Mehtap. “Determination of the effects of inflammatory markers on mortality in intensive care patients”. Journal of Cukurova Anesthesia and Surgical Sciences 5/3 (01 Aralık 2022): 389-396. https://doi.org/10.36516/jocass.1187288.
JAMA
1.Honca T, Parlak A, Öz H, Sarer E, Honca M. Determination of the effects of inflammatory markers on mortality in intensive care patients. J Cukurova Anesth Surg. 2022;5:389–396.
MLA
Honca, Tevfik, vd. “Determination of the effects of inflammatory markers on mortality in intensive care patients”. Journal of Cukurova Anesthesia and Surgical Sciences, c. 5, sy 3, Aralık 2022, ss. 389-96, doi:10.36516/jocass.1187288.
Vancouver
1.Tevfik Honca, Ayşegül Parlak, Hakan Öz, Ebru Sarer, Mehtap Honca. Determination of the effects of inflammatory markers on mortality in intensive care patients. J Cukurova Anesth Surg. 01 Aralık 2022;5(3):389-96. doi:10.36516/jocass.1187288

Cited By

Bu dergide yayımlanan tüm içerik, Creative Commons Atıf-GayriTicari-TürevEserYok 4.0 Uluslararası Lisansı (CC BY-NC-ND 4.0) kapsamında lisanslanmıştır.

download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiYnktbmMtbmRbMV0ucG5nIiwicGF0aCI6ImRjMmUvOGY3Mi8yOTAyLzY5ZjRiZGU2NDlkMDUzLjM0MjgyNDcwLnBuZyIsImV4cCI6MTc3NzY1MDY3OCwibm9uY2UiOiJmODZhMDJlNWQ5M2M3N2JhMjUzYjMzOTE3OTI1NGNiMyJ9.fEXKQdlZxq9vl1s_qY4iq7tJSpiFA7z3ZyfKXacu1Ao

🔗 https://creativecommons.org/licenses/by-nc-nd/4.0/